RSS

Probiodrug

Biopharmaceutical company Probiodrug AG have announced the first results of a preclinical combination trial targeting pGlu-Abeta, a peptide thought to play a role in Alzheimer’s disease progression. more

News

Probiodrug, a biopharmaceutical company developing therapeutic products to treat Alzheimer's disease has entered into a collaboration with Dutch biotech Crossbeta Biosciences more

News

Probiodrug, a developer of novel therapeutic solutions to treat Alzheimer’s, will fund research at the laboratory of Cynthia Ann Lemere, PhD, a neuroscientist at the Ann Romney Center for Neurologic Diseases at Brigham and Women's Hospital. more

News